The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data

Martin Stockler describes the Enzalutamide in First-Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET) trial, which shows mixed effects of enza on QOL in prostate cancer.